Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors
Alexandra E. Gould(Takeda (United States)), Katherine Galvin(Takeda (United States)), Ryan Chau(Takeda (United States)), M. D. Smith(Millennium Engineering and Integration (United States)), O. Petter Veiby(Millennium Engineering and Integration (United States)), Emily F. Calderwood(Millennium Engineering and Integration (United States)), Mansoureh Rezaei(Millennium Engineering and Integration (United States)), Jeffery Gaulin(Millennium Engineering and Integration (United States)), Tricia J. Vos(Millennium Engineering and Integration (United States)), Paul D. Greenspan(Takeda (United States)), Misook Kim(Takeda (United States)), Cheryl A. Farrer(Millennium Engineering and Integration (United States)), Saurabh Menon(Takeda (United States)), Kathleen Aertgeerts(Fleet Science Center), Michael D. Sintchak(Millennium Engineering and Integration (United States)), Ming Tregay(Millennium Engineering and Integration (United States)), Štěpán Vyskočil(Scripps Research Institute), Jane X. Liu(Millennium Engineering and Integration (United States)), Hongbo Zeng(Nanjing Agricultural University), Christelle C. Renou(Millennium Engineering and Integration (United States)), Stephen G. Stroud(Millennium Engineering and Integration (United States)), Nancy E. Forsyth(Millennium Engineering and Integration (United States)), Jason K. Yano(Fleet Science Center), Natalia Iartchouk(Millennium Engineering and Integration (United States)), Ruth Adams(Millennium Engineering and Integration (United States)), Dave Janowick(Takeda (United States)), Ribo Guo(Millennium Engineering and Integration (United States)), R. Scott Rowland(Millennium Engineering and Integration (United States)), Matthew O. Duffey(Takeda (United States)), Erin Paske(Millennium Engineering and Integration (United States)), Shih‐Chung Huang(Kaohsiung Armed Forces General Hospital), Tianlin Xu(Takeda (United States)), Steven Langston(Takeda (United States)), Roushan Afroze(Takeda (United States)), Hirotake Mizutani(Millennium Engineering and Integration (United States)), Li‐Ting Ma(Takeda (United States)), Dylan B. England(Takeda (United States)), Qin Zhang(Nanfang Hospital), Yuan Tian(Millennium Engineering and Integration (United States)), Juliet Williams(Millennium Engineering and Integration (United States)), Khristofer Garcia(Millennium Engineering and Integration (United States)), Dong Mei Zhang(Millennium Engineering and Integration (United States)), Jouhara Chouitar(Millennium Engineering and Integration (United States)), Sean J. Harrison(Millennium Engineering and Integration (United States)), B. K. KULKARNI(Millennium Engineering and Integration (United States)), Johnny Yang(Millennium Engineering and Integration (United States)), Sharmila Adhikari(Millennium Engineering and Integration (United States)), Christopher Blackburn(Millennium Engineering and Integration (United States))
Cited by 33
Related Papers
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|505
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453